HomeACADEMIA
ACADEMIA

Hematology Specialist Advises Caution in Using Hemlibra in Children
(Oct.30.2018)

Dr Nobuaki Suzuki at Shire media seminar
A hematology specialist called for careful consideration when using Chugai Pharmaceutical’s hemophilia treatment Hemlibra (emicizumab) in children as its additional indication could greatly expand its target patients in Japan ...
(LOG IN FOR FULL STORY)